Renal Cell Cancer Update

Dr Maha Hussain discusses the role of PARP inhibitors in the treatment of prostate cancer. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayAACR20).

Dr Joaquim Bellmunt from the Beth Israel Deaconess Medical Center in Boston discusses the use of immune checkpoint inhibitors in urothelial bladder carcinoma. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayCheckpointInhibitionUBC20).

Dr David O’Malley from the Ohio State University and The James Cancer Center in Columbus discusses the current and future roles of immune checkpoint inhibitors and other novel therapies in the management of gynecologic cancers. CME information and select publications here (https://www.researchtopractice.com/OncologyTodaySGOImmuno20).

Dr Andrew Ko from the University of California, San Francisco discusses recently published and emerging research in the management of pancreatic cancer. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayPancreaticCancer20).

Dr Philip A Philip from the Karmanos Cancer Institute in Detroit, Michigan, discusses recent data sets in gastrointestinal cancers from the ASCO and ESMO 2020 meetings that are most likely to have an impact on clinical practice. Faculty information and select publications here (https://www.researchtopractice.com/OncologyTodayGIJournalClub20).

Dr Sylvia Adams from the Perlmutter Cancer Center in New York discusses recently published and emerging research on the use of immune checkpoint inhibition in breast cancer. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayCheckpointInhibitionBC20).

Dr Eric Klein from the Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio, discusses the role of liquid biopsy for cancer detection, including his experience with the Circulating Cell-Free Genome Atlas study. Faculty information and select publications here (https://www.researchtopractice.com/OncologyTodayLiquidBiopsy20).

Dr Peter Voorhees from the Levine Cancer Institute in Charlotte, North Carolina, discusses novel agents under investigation in multiple myeloma. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayMMNovelAgents20).

Professor Stephen Johnston from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London discusses the role of CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayERPositiveEarlyBC20).

Dr Ross Camidge from the University of Colorado in Denver discusses recently published and emerging research in the management of non-small cell lung cancer with ALK and ROS1 rearrangements. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayALKNSCLC20).

Dr Daniel Catenacci from the University of Chicago Medicine and Biological Sciences discusses recently published and emerging research in the management of gastroesophageal cancers. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayGastric20).

Dr Ashish Kamat from the University of Texas MD Anderson Cancer Center in Houston discusses recently published and emerging research on the use of immune checkpoint inhibitors and other novel therapies for patients with urothelial bladder cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayAUABladder20).

For this special edition of Oncology Today, I met with Dr Chung-Han Lee from the Memorial Sloan Kettering Cancer Center in New York to discuss recently published and emerging research on the management of renal cell carcinoma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayRCC20).

For this special edition of Oncology Today, I met with Dr Keith Pratz from the University of Pennsylvania in Philadelphia to discuss recently published and emerging research in the use of FLT3 inhibitors for patients with acute myeloid leukemia. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayAMLFLT320).

For this special edition of Oncology Today, I met with Dr Tanya Siddiqi from the City of Hope National Medical Center in Duarte, California, to discuss recently published and emerging research in the use of chimeric antigen receptor T-cell therapy for patients with non-Hodgkin lymphoma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayCARTNHL20).

For this special edition of Oncology Today, I met with Dr Kim Reiss Binder from the Abramson Cancer Center in Philadelphia to discuss recently published and emerging research on the use of PARP inhibitors in pancreatic cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPARPPanc20).

For this special edition of Oncology Today, I met with Dr Courtney DiNardo from the MD Anderson Cancer Center in Houston, Texas, to discuss recently published and emerging research on the management of acute myeloid leukemia not eligible for intensive induction therapy. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayAMLIntensiveTx20).

For this special edition of Oncology Today, I met with Dr John Pagel from the Swedish Cancer Institute in Seattle to discuss recently published and emerging research in the front-line treatment of chronic lymphocytic leukemia. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayFrontLineCLL20/).

For this special edition of Oncology Today, I met with Dr Craig Moskowitz from the University of Miami Sylvester Comprehensive Cancer Center to discuss recently published and emerging research for the treatment of Hodgkin lymphoma. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayHL20).

For this special edition of Oncology Today, I met with Dr Jeffrey Lancet from the Moffitt Cancer Center in Tampa, Florida, to discuss recently published and emerging research on induction and maintenance strategies for patients with acute myeloid leukemia. CME information and select publications here (http://www.researchtopractice.com/oncologytodayAMLInduction20).